US Stock MarketDetailed Quotes

AGIO Agios Pharmaceuticals

Watchlist
  • 39.020
  • -2.940-7.01%
Close Dec 18 16:00 ET
  • 39.500
  • +0.480+1.23%
Pre 05:30 ET
2.23BMarket Cap3.35P/E (TTM)

About Agios Pharmaceuticals Company

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Company Profile

SymbolAGIO
Company NameAgios Pharmaceuticals
Listing DateJul 24, 2013
Issue Price18.00
Founded2007
CEOMr. Brian Goff
MarketNASDAQ
Employees386
Fiscal Year Ends12-31
Address88 Sidney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139-4169
Phone1-617-649-8600
Websitehttp://www.agios.com

Company Executives

  • Name
  • Position
  • Salary
  • Brian Goff
  • Chief Executive Officer and Director
  • 3.42M
  • James William Burns
  • Chief Legal Officer
  • 1.93M
  • Tsveta Milanova
  • Chief Commercial Officer
  • 3.73M
  • Cecilia Jones
  • Chief Financial Officer
  • 1.21M
  • Dr. Sarah Gheuens, M.D.,PhD
  • Chief Medical Officer and Head of Research and Development
  • 2.87M
  • T. J. Washburn
  • Principal Accounting Officer, Vice President and Controller
  • --
  • Dr. Jacqualyn A. Fouse, PhD
  • Chairman of the Board
  • 447.25K
  • Kaye Foster
  • Lead Independent Director
  • 440.95K
  • Jeffrey D. Capello
  • Independent Director
  • 663.68K
  • Catherine Owen
  • Independent Director
  • 659.94K
  • Dr. Rahul D. Ballal, PhD
  • Independent Director
  • 427.25K
  • Cynthia Smith
  • Independent Director
  • 419.91K
  • Dr. Maykin Ho, PhD
  • Independent Director
  • 424.75K
  • Dr. David T. Scadden, M.D.
  • Independent Director
  • 429.75K
  • Dr. David P. Schenkein, M.D.
  • Independent Director
  • 417.25K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Apple
AAPL
-2.14%
Oracle
ORCL
-2.53%
Adobe
ADBE
-3.06%
Ecopetrol
EC
-3.17%
D.R. Horton
DHI
-3.37%

Unlock the Full List